Author William Breathes

Congrats, Travers Narcotics team: you raided a marijuana dispensary that wasn’t trying to hide what they were doing and have prevented patients from accessing state-legal cannabis they use as medicine.
Cops raided the Magic Buds Medical Cannabis store in Wexford County, Michigan Tuesday, taking cash, business and patient records along with the stock of medical cannabis. The raid came after a judge ordered the shop to close last month for operating against state laws that prohibit dispensaries.

A proposed law that would have established policing of marijuana dispensaries statewide was essentially killed in the California legislature last week.
Dale Gieringer, state coordinator of California NORML, says it’s now time to take the matter directly to voters. He envisions the possibility, in 2016, of an initiative that would ask you to approve both the legalization of recreational marijuana and the creation of a regulatory framework for all pot retailers. That could mean having the California Department of Alcoholic Beverage Control act as police for medical and recreational shops. More at the LA Weekly.

Nevada’s head of the state medical marijuana program says that, pending local approval, medical marijuana dispensaries could open in “early” 2015.
But first, the state will have to grant licenses. Yesterday marked the last day Nevada medical marijuana business hopefuls could drop off applications. Roughly 370 people applied, and out of that 66 will be chosen.

Earlier this month, high-ranking folks from the health department staffers gave an all-day presentation about pot. They urged the public to take a look at the first draft of rules governing the program, as well as the application for growers, and be honest.
In response, the DC-based Marijuana Policy Project, whose lobbyists played a key role in getting legislation passed here, submitted a six-page critique. The goal, writes Robert Capecchi, a deputy director, should be to avoid regulating the growers out of business while offering protections for patients and the facilities that produce the medicine.